Photocure ASA: Results for the fourth quarter of 2020
Oslo, Norway, 3 March 2021: Photocure ASA (OSE:PHO) reports Hexvix[®]/Cysview[®] revenues of NOK 97.7 million in the fourth quarter of 2020 (Q4 2019: NOK 58.8). Product revenues increased 20% in FY2020 representing strong execution in an unprecedented year. Due to the ongoing pandemic, the Company suspends guidance for its 2023 revenue ambition in the range of NOK 1 billion. Photocure plans to re-issue financial guidance once the impact from Covid-19 is significantly diminished and physician practices and patient flow have normalized in both the U.S. and Europe.“Photocure grew sales in 2020